The role of the sFRP4 protein in modulation of cancer growth and anti-neoplastic drug sensitivity
MetadataShow full item record
This project found that reintroducing a regulatory protein, sFRP4, to mesothelioma cancer cell models could inhibit their growth, ability to migrate and induce a form of cell death. In addition sFRP4 could sensitise mesothelioma cells to drug treatment. The mechanisms involved were studied in detail and the project provided new insights into the functions of this protein including identifying the protein structures involved in these effects and its role in cancer cells.
Showing items related by title, author, creator and subject.
Lim, Raelene (2003)Myeloid Leukemia Factor 1 (Mlf1) is the murine homolog of MLF1, which was identified as a fusion gene with Nucleophosmin (NPM) resulting from the (3;5)(q25.1;q34) translocation associated with acute myeloid leukemia and ...
Molecular mechanism underlying aberrant expression of the connective tissue growth factor in paediatric pre-B cell acute lymphoblastic leukemiaWelch, Mathew D. (2011)Acute lymphoblastic leukaemia (ALL) is the most common cancer diagnosed in children aged 1-14 years. There have been vast improvements in clinical outcomes for children diagnosed with ALL with cure rates of up to 90% ...
Chang, Elizabeth; Sidhu, Amandeep; Sidhu, B.; Dillon, Tharam S. (2005)The rapid generation of accessible protein data sources has generated confusion over protein data representation. The protein ontology project seeks to provide a set of structured vocabularies for protein domains that can ...